NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak 
3 clinical-grade skincare creams you really shouldn’t buy online 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
A recently published study sparks hope that the world is getting closer to developing a cure for the human immunodeficiency virus (HIV). Scientists reported finding the kill switch to dormant reservoirs of the virus in a patient’s body.
HIV cure: Elimination of virus is possible, study shows
Much like cancer, HIV infection remains one of the most difficult medical science challenges today because experts have yet to develop a cure that would eliminate it from the body. On the bright side, decades of study have resulted in the development of antiretroviral therapy that practically keeps HIV at bay. ART is usually administered through a pill that patients need to take daily.
ART drugs make HIV inactive and remain in reservoirs in a patient’s body. So when the patient stops taking their ART medication, the virus is reactivated and often causes more serious damage to the body.
This characteristic of HIV is what makes the research by scientists from the University of California, San Diego (UCSD) School of Medicine so important. The study, published in mBio, reports finding a switch that helps in the spread of HIV in the body after conducting the first-ever genome-wide expression analysis of long noncoding RNA (lncRNA) in HIV-infected macrophages.
Simply put, lncRNAs are responsible for regulating genes in the cells that means these also act as an on-and-off switch. The experiment led scientists to identify the HIV-1 Enhanced LncRNA (HEAL) that is now regarded as the key to further understanding how HIV replicates even in immune cells and how to stop it from doing so. The research is a proof of the concept that HEAL plays a key role in preventing HIV from being reactivated even after a patient stops taking ART drugs.
Is it possible to cure HIV?
Almost 38 million people are living with HIV all over the world per the report of UNAIDS, and around 1.7 million of those were newly recorded cases. This means that despite the availability of ART and pre-exposure prophylaxis (PrEP) drugs against HIV, it remains one of the biggest health crises globally.
However, not all hope is lost. The research mentioned above is not the only one that has proven there is a way to kill HIV. It is only a matter of time for scientists to use these breakthroughs in developing a complete cure.
